《福布斯》公布 2018 年 30 岁以下最佳创业者及项目

每年《福布斯》杂志召集编辑和业内大咖评选年度在医学健康领域 30 岁以下的青年成功创业者。今年的青年俊才和创业者所展示的创业领域和获得的成果集中在以下三大领域:基因编辑、抗癌方案和智能手机 App。

《福布斯》每年评选最佳创业者,目的之一是关注新一代创业者们探索的崭新领域。历年来,药物创新研发是热门领域之一。近年来随着医疗大健康领域疆土的拓展和交叉科技成果的渗透应用,青年创业者已经开始选择或探寻新的热点,甚至是从未有人进入的“处女地”。

比如说:Leah Sibener 和 Marvin Gee,26 岁。曾在斯坦福大学著名生物学家门下就读,他们创新研发的是一种新型白细胞,用于治疗癌症。他们的研发独到之处在于开发了一种机器学习功能,来识别和驯化 T 细胞。他们的创业项目已经获得 1200 万美元的风险投入支持。

更多详细报道请阅读原文:

The Forbes 30 Under 30 in Healthcare was selected by Forbes editors in collaboration with an expert panel. This year, the panel was comprised of Cigall Kadoch Assistant Professor of Pediatric Oncology, Dana-Farber Cancer Institute and an Under 30 alum, Peter Bach, Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes, and Steven Salzberg,the Bloomberg Distinguished Professor of Biomedical Engineering, Computer Science, and Biostatistics at Johns Hopkins University.

There’s no denying that the list has always had a pharma presence. Flatiron health co-founder and CEO Nat Turner veiwed pharma companies as clients. Martin Shkreli, who became infamous for a drug price hike, was featured on our Finance list in 2012. Vivek Ramaswamy, a 2014 lister, founded a whole network of biotech companies and took Axovant, focused on Alzheimer’s drugs, public in a $360 million 2015 IPO only to see the company’s lead drug fail earlier this year. But this represents a better bumper crop of baby Pharmas than we’ve ever had.

A related efflorescence: the number of Under 30s working with the gene-editing technology CRISPR, a set of proteins discovered in bacteria (originally, bacteria involved in making yogurt!) that can be used to cut and edit DNA in living things with previously impossible exactness. Kunwoo Lee co-authored a paper showing that CRISPR could be used to treat muscular dystrophy in mice. His startup, GenEdit, has raised $1.5 million to deliver CRISPR into the body using nanoparticles. Andreas Puschnik, the first fellow of the Chan Zuckerberg BioHub, is using CRISPR to develop new experimental drugs for Zika and dengue fever. Omar Abudayyeh and Jonathan Gootenberg, students in the laboratory of Broad Institute wunderkind Feng Zhang, developed a new CRISPR enzyme for use in gene editing and another that could be used for DNA’s sister chemical RNA, which the body uses as a chemical messenger.

Not that the digital revolution in healthcare is slowing at all. Siddarth Satish’s Gauss Surgical has raised $24.6 million for a product that uses the iPad’s built-in camera and computer vision algorithms to measure blood loss after childbirth. Alamin Uddin and Waleed Asif have founded NexHealth, which has raised $7 million to help doctor’s offices simplify paperwork and schedule appointments. A foursome — Manik Bhat, Eric Conner, Dan Levenson and Alex Villa — raised $9.6 million for Healthify, which connects Medicaid recipients to social services. And then there are some shocking ideas. Oren Miron thinks an auditory test might be used to diagnose autism. Kevin Eisenfrats is working on a male birth control that uses hydrogel to block sperm.

Not every gamechanger is an entrepreneur. Doug Jacobs shone a light on insurance practices that dissuade patients from getting care — leading the Department of Health and Human Services to brand those practices discrimination. And Trit Garg has improved clinical efficiency in a Stanford pilot program and lobbied the Centers for Medicare & Medicaid Services to impose tighter restrictions on the use of expensive CT scans.

全部获选名单请观赏链接内容:强烈建议 30 岁以下的创业探险者 | 必读 |:

https://www.forbes.com/30-under-30/2018/healthcare/#4c977028662b

发表评论

电子邮件地址不会被公开。 必填项已用*标注